Summary

Health insurance companies are increasingly denying cancer treatments and screenings recommended by physicians, leading to delays and potential harm for patients.

These denials, often based on internal rules lacking transparency, can result in serious adverse events, disease progression, and even death.

While prior authorization is intended to save money, physicians argue that the current system is inefficient and detrimental to patient care.